BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16699469)

  • 1. Emergence of hepatitis B infection despite antibodies to hepatitis B surface antigen: a new nosocomial risk in patients with end-stage renal disease.
    Moal V; Vacher-Coponat H; Botelho E; Berland Y; Colson P; Tamalet C; Henry M
    Transplantation; 2006 May; 81(9):1358-9. PubMed ID: 16699469
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen.
    Olde C; Garcia M
    J CANNT; 1998; 8(4):20-1. PubMed ID: 10196927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological markers of hepatitis in hemodialysis patients and staff.
    Kelly TJ; Hourani MR; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():179-82. PubMed ID: 756042
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to hepatitis B vaccination in haemodialysis patients and healthy medical staff.
    Ton SH; Duraisamy G; Noriah R; Thiruselvam A; Lopez CG; Suleiman AB
    Singapore Med J; 1986 Apr; 27(2):120-3. PubMed ID: 2944217
    [No Abstract]   [Full Text] [Related]  

  • 6. [Australia antigen and the agents of hepatitis. Serologic methods for detection and electron microscopy].
    German A; Couleru O; Panouse-Perrin J; Peter F
    Prog Immunobiol Stand; 1971; 5():55-62. PubMed ID: 4144998
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and significance of antibodies to hepatitis delta-antigen in hepatitis B viral infection].
    Jelić O; Jelić D; Balen I; Mihaljević I; Dominis M
    Acta Med Iugosl; 1987; 41(2):127-37. PubMed ID: 3618296
    [No Abstract]   [Full Text] [Related]  

  • 9. HBeAg and anti-HBe in chronic hepatitis B virus infection.
    Chen DS; Sung JL; Lai MY
    Gastroenterology; 1981 Apr; 80(4):880-2. PubMed ID: 7202958
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Delta antigen-antibody system in hepatitis B].
    Brauman A; Eshchar J
    Harefuah; 1982; 103(12):369-70. PubMed ID: 7183494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of hepatitis B among housestaff.
    Conrad ME; Knodell RG; Bell CJ; Armanious MW
    Ala J Med Sci; 1976 Jan; 13(1):74-6. PubMed ID: 1251979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccination against Hepatitis B Virus in chronic renal disease patients].
    Franco E; Senatore S; Ruggiero F; Papa R; Zaratti L
    Ig Sanita Pubbl; 2008 Jan; 64(1):131-6. PubMed ID: 18379610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus B hepatitis in hemodialysis centers.
    Soulier JP; Jungers P; Zingraff J
    Adv Nephrol Necker Hosp; 1976; 6():383-411. PubMed ID: 828452
    [No Abstract]   [Full Text] [Related]  

  • 16. [Infection by B virus in a hemodialysis unit. Epidemiologic study].
    Flores Alvarado A; Sommer Cervantes H; Rattoni Núñez N
    Prensa Med Mex; 1978; 43(3-4):83-8. PubMed ID: 724647
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of nine year prevalence of hepatitis B surface antigen at the hospital of the University of Pennsylvania.
    Cameron EM; Neff ML
    J Am Assoc Nephrol Nurses Tech; 1981 Dec; 8(6):30-1, 44. PubMed ID: 6915064
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathology of hepatitis B.
    Bianchi L; Gudat F
    Prog Liver Dis; 1979; 6():371-92. PubMed ID: 396564
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with the detection of hepatitis B in the active epidemiological surveillance at a department of hemodialysis and kidney transplantation].
    Solt K; Hollós I; Pintér J; Hronszky I
    Orv Hetil; 1975 Feb; 116(8):428-31. PubMed ID: 1089944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.